Loading...
XNASALGN
Market cap15bUSD
Dec 24, Last price  
215.50USD
1D
2.86%
1Q
-11.94%
Jan 2017
122.10%
Name

Align Technology Inc

Chart & Performance

D1W1MN
XNAS:ALGN chart
P/E
36.15
P/S
4.17
EPS
5.96
Div Yield, %
0.00%
Shrs. gr., 5y
-1.21%
Rev. gr., 5y
14.45%
Revenues
3.86b
+3.42%
172,830,000207,125,000206,354,000284,332,000303,976,000312,333,000387,126,000479,741,000560,041,000660,206,000761,653,000845,486,0001,079,874,0001,473,413,0001,966,492,0002,406,796,0002,471,941,0003,952,584,0003,734,635,0003,862,260,000
Net income
445m
+23.09%
8,768,0001,413,000-34,963,00035,724,00079,987,000-31,269,00074,253,00066,716,00058,691,00064,295,000145,832,000144,020,000189,682,000231,418,000400,235,000442,776,0001,775,888,000772,020,000361,573,000445,053,000
CFO
786m
+38.16%
24,562,00016,088,000-14,030,00052,777,00039,746,00074,165,000129,529,000130,469,000133,778,000185,976,000226,899,000237,997,000247,654,000438,539,000554,681,000747,270,000662,174,0001,172,544,000568,732,000785,776,000
Earnings
Jan 29, 2025

Profile

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
IPO date
Jan 26, 2001
Employees
22,910
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
3,862,260
3.42%
3,734,635
-5.51%
3,952,584
59.90%
Cost of revenue
1,502,227
1,406,118
1,267,544
Unusual Expense (Income)
NOPBT
2,360,033
2,328,517
2,685,040
NOPBT Margin
61.10%
62.35%
67.93%
Operating Taxes
196,151
237,484
240,403
Tax Rate
8.31%
10.20%
8.95%
NOPAT
2,163,882
2,091,033
2,444,637
Net income
445,053
23.09%
361,573
-53.17%
772,020
-56.53%
Dividends
Dividend yield
Proceeds from repurchase of equity
(565,765)
(408,887)
(349,415)
BB yield
2.70%
2.47%
0.67%
Debt
Debt current
29,651
26,574
22,719
Long-term debt
193,936
200,668
205,312
Deferred revenue
160,662
136,684
Other long-term liabilities
289,809
320,368
292,669
Net debt
(757,177)
(814,320)
(1,068,631)
Cash flow
Cash from operating activities
785,776
568,732
1,172,544
CAPEX
(177,716)
(291,900)
(401,098)
Cash from investing activities
(195,943)
(213,316)
(563,430)
Cash from financing activities
(598,340)
(501,686)
(458,332)
FCF
2,105,755
1,943,481
2,058,728
Balance
Cash
972,742
999,584
1,171,342
Long term investments
8,022
41,978
125,320
Excess cash
787,651
854,830
1,099,033
Stockholders' equity
2,468,349
2,556,412
2,623,708
Invested Capital
3,259,266
3,280,143
3,044,571
ROIC
66.18%
66.12%
84.80%
ROCE
58.32%
58.59%
67.01%
EV
Common stock shares outstanding
76,568
78,420
79,670
Price
274.00
29.92%
210.90
-67.91%
657.18
22.98%
Market cap
20,979,632
26.85%
16,538,778
-68.41%
52,357,531
23.66%
EV
20,222,455
15,724,458
51,288,900
EBITDA
2,502,434
2,454,310
2,793,769
EV/EBITDA
8.08
6.41
18.36
Interest
5,367
36,023
Interest/NOPBT
0.23%
1.34%